Stephen Gucker

Array ( [id] => 5727464 [patent_doc_number] => 20060058224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Methods of treating obesity with combination therapeutics' [patent_app_type] => utility [patent_app_number] => 11/229426 [patent_app_country] => US [patent_app_date] => 2005-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3193 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20060058224.pdf [firstpage_image] =>[orig_patent_app_number] => 11229426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5873045 [patent_doc_number] => 20060165731 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Vaccines' [patent_app_type] => utility [patent_app_number] => 11/224318 [patent_app_country] => US [patent_app_date] => 2005-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6129 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20060165731.pdf [firstpage_image] =>[orig_patent_app_number] => 11224318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4771396 [patent_doc_number] => 20080057054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'Modulation of Phagocytosis in Neurons' [patent_app_type] => utility [patent_app_number] => 11/662528 [patent_app_country] => US [patent_app_date] => 2005-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12629 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20080057054.pdf [firstpage_image] =>[orig_patent_app_number] => 11662528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4916379 [patent_doc_number] => 20080096980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-24 [patent_title] => 'Methods and Compositions for Reducing a Level of a Toxic Protein in a Cell' [patent_app_type] => utility [patent_app_number] => 11/572980 [patent_app_country] => US [patent_app_date] => 2005-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18879 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20080096980.pdf [firstpage_image] =>[orig_patent_app_number] => 11572980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4860269 [patent_doc_number] => 20080269119 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Ophthalmic Device and Related Methods and Compositions' [patent_app_type] => utility [patent_app_number] => 11/660135 [patent_app_country] => US [patent_app_date] => 2005-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13964 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20080269119.pdf [firstpage_image] =>[orig_patent_app_number] => 11660135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5672096 [patent_doc_number] => 20060177450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Prostate-specific membrane antigen' [patent_app_type] => utility [patent_app_number] => 11/202940 [patent_app_country] => US [patent_app_date] => 2005-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 24073 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20060177450.pdf [firstpage_image] =>[orig_patent_app_number] => 11202940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5820444 [patent_doc_number] => 20060024757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Detection of oncofetal fibronectin for selection of concepti' [patent_app_type] => utility [patent_app_number] => 11/193561 [patent_app_country] => US [patent_app_date] => 2005-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 165158 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20060024757.pdf [firstpage_image] =>[orig_patent_app_number] => 11193561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4995514 [patent_doc_number] => 20070010859 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'Methods of enhancing the immune response to autoantigens in mucosal associated lymphatic tissue' [patent_app_type] => utility [patent_app_number] => 11/176437 [patent_app_country] => US [patent_app_date] => 2005-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6769 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20070010859.pdf [firstpage_image] =>[orig_patent_app_number] => 11176437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4812809 [patent_doc_number] => 20080193440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Method For Multiple Sclerosis Treatment and Prophylaxis By Treatment of Leptospira Infection' [patent_app_type] => utility [patent_app_number] => 11/571478 [patent_app_country] => US [patent_app_date] => 2005-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 27575 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20080193440.pdf [firstpage_image] =>[orig_patent_app_number] => 11571478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4833334 [patent_doc_number] => 20080131881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'Markers For Brain Damage' [patent_app_type] => utility [patent_app_number] => 11/630582 [patent_app_country] => US [patent_app_date] => 2005-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 7663 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20080131881.pdf [firstpage_image] =>[orig_patent_app_number] => 11630582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5726799 [patent_doc_number] => 20060057559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'High-throughput cell migration screening assay' [patent_app_type] => utility [patent_app_number] => 11/166920 [patent_app_country] => US [patent_app_date] => 2005-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 33418 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20060057559.pdf [firstpage_image] =>[orig_patent_app_number] => 11166920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5769412 [patent_doc_number] => 20050265969 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Therapeutic chemokine receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/136097 [patent_app_country] => US [patent_app_date] => 2005-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13980 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20050265969.pdf [firstpage_image] =>[orig_patent_app_number] => 11136097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7019417 [patent_doc_number] => 20050221436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Human neuropeptide Y-like G protein-coupled receptor' [patent_app_type] => utility [patent_app_number] => 11/133283 [patent_app_country] => US [patent_app_date] => 2005-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 24761 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20050221436.pdf [firstpage_image] =>[orig_patent_app_number] => 11133283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5769439 [patent_doc_number] => 20050265981 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Transdifferentiation of glial cells' [patent_app_type] => utility [patent_app_number] => 11/130027 [patent_app_country] => US [patent_app_date] => 2005-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5948 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20050265981.pdf [firstpage_image] =>[orig_patent_app_number] => 11130027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5793134 [patent_doc_number] => 20060013815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Human Mob-5 (IL-24) receptors and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/124925 [patent_app_country] => US [patent_app_date] => 2005-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18380 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20060013815.pdf [firstpage_image] =>[orig_patent_app_number] => 11124925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 267004 [patent_doc_number] => 07566528 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-28 [patent_title] => 'Method for the identification and/or validation of receptor tyrosine kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/112344 [patent_app_country] => US [patent_app_date] => 2005-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4086 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/566/07566528.pdf [firstpage_image] =>[orig_patent_app_number] => 11112344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6925884 [patent_doc_number] => 20050239139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Transmissible spongiform encephalopathy test reagents and methods' [patent_app_type] => utility [patent_app_number] => 11/099128 [patent_app_country] => US [patent_app_date] => 2005-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6927 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20050239139.pdf [firstpage_image] =>[orig_patent_app_number] => 11099128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4739459 [patent_doc_number] => 20080233112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'Treatment of Diseases' [patent_app_type] => utility [patent_app_number] => 11/547644 [patent_app_country] => US [patent_app_date] => 2005-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4554 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20080233112.pdf [firstpage_image] =>[orig_patent_app_number] => 11547644 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6957918 [patent_doc_number] => 20050214288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Antibodies against Nogo receptor' [patent_app_type] => utility [patent_app_number] => 11/090836 [patent_app_country] => US [patent_app_date] => 2005-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 78535 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20050214288.pdf [firstpage_image] =>[orig_patent_app_number] => 11090836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7247306 [patent_doc_number] => 20050272094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Purified antigen for Alzheimer\'s disease and methods of obtaining and using same' [patent_app_type] => utility [patent_app_number] => 11/074958 [patent_app_country] => US [patent_app_date] => 2005-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14404 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20050272094.pdf [firstpage_image] =>[orig_patent_app_number] => 11074958 [rel_patent_id] =>[rel_patent_doc_number] =>)